(Q33716414)

English

Pharmacologic therapy for type 2 diabetes mellitus

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

title

Pharmacologic therapy for type 2 diabetes mellitus (English)

1 reference

stated in

Europe PubMed Central

28 July 2017

0 references

1 reference

1

DeFronzo RA

1 reference

stated in

Europe PubMed Central

PubMed ID

10454950

retrieved

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

stated in

Europe PubMed Central

28 July 2017

Annals of Internal Medicine

1 reference

stated in

Europe PubMed Central

28 July 2017

131

1 reference

stated in

Europe PubMed Central

28 July 2017

281-303

1 reference

stated in

Europe PubMed Central

28 July 2017

4

1 reference

stated in

Europe PubMed Central

28 July 2017

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIACARE.18.6.817

Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI109108

Identifiers

DOI

10.7326/0003-4819-131-4-199908170-00008

1 reference

stated in

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

PubMed ID

10454950

retrieved

28 July 2017

(Q33716414)

Pharmacologic therapy for type 2 diabetes mellitus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)